Additional studies, revealing the effects of TDP-43 interactors with the potential to reduce or accelerate TDP-43 aggregation in combination with different mutations of ALS-associated genes, are definitely needed. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.